Transcode Therapeutics, Inc. - COM NEW (RNAZ)

Historical Portfolio Holders from Q4 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
262K
Holdings value Q2 2024
$263K
Value change Q2 2024
-$47K
Grand Portfolio weight change Q2 2024
0%
Number of holders
14
Number of buys Q2 2024
11
Number of sells Q2 2024
-4
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 262K $263K -$47K $1.01 14
2024 Q1 417K $284K +$276K $0.68 5
2023 Q4 50K $8.24K +$8.24K $0.16 1